Table 4.
Univariable and multivariable logistic regression analysis for transurethral coagulation
| Variable | Univariable analysis |
Multivariable analysis |
||
|---|---|---|---|---|
| Unadjusted OR (95% Cl) | P-value | Adjusted OR (95% Cl) | P-value | |
| Age | 1.03 (1.01–1.04) | 0.002 | - | - |
| 5-ARI | 1.58 (1.23–2.04) | < 0.001 | - | - |
| PSA | 1.07 (1.04–1.10) | < 0.001 | - | - |
| TPV | 1.02 (1.01–1.02) | < 0.001 | - | - |
| TZV | ||||
| Q1 (0–22.2) | 1.00 | - | 1.00 | - |
| Q2 (22.3–34.0) | 1.44 (0.91–2.27) | 0.117 | 1.42 (0.90–2.25) | 0.132 |
| Q3 (34.1–53.4) | 2.45 (1.60–3.76) | < 0.001 | 2.42 (1.58–3.72) | < 0.001 |
| Q4 (≥ 53.5) | 5.19 (3.45–7.79) | < 0.001 | 5.17 (3.44–7.77) | < 0.001 |
OR, odds ratio; CI, confidence interval; 5-ARI, 5-alpha reductase inhibitor; PSA, prostate-specific antigen; TPV, total prostate volume; TZV, transition zone volume; Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile.